Abstract
Targeting regulatory signaling pathways that control human bone marrow stromal (skeletal or mesenchymal) stem cell (hBMSC) differentiation and lineage fate determination is gaining momentum in the regenerative medicine field. Therefore, to identify the central regulatory mechanism of osteoblast differentiation of hBMSCs, the molecular phenotypes of two clonal hBMSC lines exhibiting opposite in vivo phenotypes, namely, bone forming (hBMSC(+bone)) and non-bone forming (hBMSC(-Bone)) cells, were studied. Global transcriptome analysis revealed significant downregulation of several TGF & beta; responsive genes, namely, TAGLN, TMP1, ACTA2, TGF & beta;2, SMAD6, SMAD9, BMP2, and BMP4 in hBMSC(-Bone) cells and upregulation on SERPINB2 and NOG. Transcriptomic data was associated with marked reduction in SMAD2 protein phosphorylation, which thereby implies the inactivation of TGF & beta; and BMP signaling in those cells. Concordantly, activation of TGF & beta; signaling in hBMSC(-Bone) cells using either recombinant TGF & beta;1 protein or knockdown of SERPINB2 TGF & beta;-responsive gene partially restored their osteoblastic differentiation potential. Similarly, the activation of BMP signaling using exogenous BMP4 or via siRNA-mediated knockdown of NOG partially restored the differentiation phenotype of hBMSC(-Bone) cells. Concordantly, recombinant NOG impaired ex vivo osteoblastic differentiation of hBMSC(+Bone) cells, which was associated with SERBINB2 upregulation. Our data suggests the existence of reciprocal relationship between TGFB and BMP signaling that regulates hBMSC lineage commitment and differentiation, whilst provide a plausible strategy for generating osteoblastic committed cells from hBMSCs for clinical applications.